Ryan J. Sullivan, MD
Articles
Risks Versus Benefits in Combining Immunotherapies
February 20, 2019
Video
Combining two checkpoint blockades can be very efficacious in treating metastatic melanoma, but the benefits come with increased risk of adverse events, too.